The Global Covid-19 Rapid Antigen test kits market is expected to reach USD 743. 07 million by 2027. Antigen tests are commonly used in the diagnosis of pathogens, including influenza viruses and respiratory syncytial viruses.
New York, June 22, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "COVID-19 Rapid Antigen Test Kits Market - Global Outlook & Forecast 2022-2027" - https://www.reportlinker.com/p06288147/?utm_source=GNW These tests are immunoassays that detect specific viral antigen and confirms the presence or absence of viral infection. Rapid antigen tests are currently authorized to be performed on nasal or nasopharyngeal swab specimens placed directly into the immunoassay’s extraction buffer or reagent. The currently available rapid antigen tests include point-of-care (POC) and laboratory-based tests, as well as self-tests performed at home, and they are commercially available to people of any age. A rapid antigen test is one of the widely used diagnostic tests to diagnose COVID-19 presence in an individual with or without symptoms. It offers a faster result and is relatively less expensive than PCR (polymerase chain reaction) or antibody tests. The global COVID-19 rapid antigen tests market is a new demanding market. The market is growing at a rapid pace due to the COVID-19 pandemic and will become a normal market like other infectious diseases. The testing plays a significant role in containing and mitigating the pandemic by identifying the infected individual and stopping further person-to-person transmission. Rapid antigen testing is one of the primarily performed COVID-19 tests globally. This diagnosis determines the portion of virus protein and can give results within 15 minutes. Initially, the PCR was considered the gold standard for COVID-19 diagnosis. However, over time, usage of rapid diagnostics kits has increased, and also, the vendors have introduced highly sensitive COVID-19 rapid tests kits. Benefits of COVID-19 Rapid Antigen Testing One of the significant advantages of people preferring rapid antigen testing devices is its quick results and more economic ability than other testing devices in the market. The demand for rapid COVID-19 antigen test kits is growing due to their low cost and easy use. The government in many countries is widely making the test kits available at a discounted price, which is one of the major factors boosting the adoption rate of home test kits. Raise in Infection Spread Multiple variants of the COVID-19 virus were identified across the globe. Governments started providing authorization for the emergency use of numerous test kits to increase access to COVID-19 tests. Countries such as the US and the UK started providing free home test kits, which has led to the high adoption of home test kits as these devices can be used without professional guidance. Technological Advancements in COVID-19 Rapid Testing Vendors designed various new rapid testing kits such as cups and cards and smart test kits, which were more sensitive and provided better results, almost equal to gold-standard PCR testing. There were painless rapid testing kits that used saliva samples. Test kits providing results in a shorter time were also introduced in the market. These advancements drive the usage of rapid testing over other COVID-19 testing kits. For instance, CoviFind COVID-19 Rapid Antigen Self-Test, a non-prescription product manufactured by Meril Diagnostics, an India-based, global medical company, has approval from ICMR for regular use in India self-test and is easily accessible. Large academic institutes, and companies distributed home test kits at no cost to their stakeholders. This was a precautionary measure and peace of mind for the students and workers, helping people decide on the pandemic. Several steps are taken by the government, corporate companies, and academic institutes to increase the usage of COVID-19 rapid testing kits. Mass Testing Strategy Among Countries & Robust Fundings for COVID-19 Testing Robust testing strategies are seen as a significant aspect of preparedness and response to the COVID-19 pandemic, early detection of infection rates, and transmission, among others. Many countries started conducting COVID-19 mass testing strategies to reduce the spread of infections. People traveling from other countries were tested in airports, and migrating within-country required covid-19 certificates. Many were also tested on the spot using rapid test kits to reduce the spread of infections. Many NGOs, large regulatory bodies, and companies started manufacturing the COVID-19 test kits to tap the opportunity in the market. The increased investments made the companies increase their production volume. This, in turn, vastly increased the opportunities for COVID-19 rapid testing in the market. One of the major limitations of rapid testing is the increased number of false-positive and negative results. There were cases with false-negative and false-positive reports in a set of COVID-19 test kits. People with COVID-19 symptoms were tested negative and tested positive when checked with alternative COVID-19 testing. These instances reduced the usage of COVID-19 rapid test kits in a few countries. Some countries like China still consider using RT-PCR tests for screening people. Developed countries like the US, Germany, the UK, France, Italy, Canada, and Spain are conducting many COVID-19 rapid tests through OTC/Home tests and healthcare settings. People in developed countries purchase home testing kits and preserve them for future use. This is not the case in developing countries. Only symptomatic people prefer buying the kits to get tested. This trend differentiates the consumption pattern among the nations. A country like Canada has ordered more rapid test kits than its population count, whereas India has not. GLOBAL COVID-19 RAPID ANTIGEN TESTING MARKET SHARE ANALYSIS Europe dominated the COVID-19 rapid testing market by geography segment. However, APAC is expected to grow at a faster rate. Due to the increased adoption of rapid testing and quicker approval of COVID-19 rapid home test kits in Europe, the COVID-19 rapid antigen test kits market in Europe will remain dominant. North America was the second-largest market with faster product approvals, launches, and better distribution of home test kits. The United States launched new initiatives like testing with treatments, which means the treatment is provided as soon as the person is tested positive. These kinds of initiatives will primarily drive the usage of rapid test kits in the US. Hospitals & Clinics were the most significant users in the COVID-19 antigen test market. Mainly professional rapid testing was used in the hospitals & clinics segments. Individual segments had faster Covid-19 antigen test kits market growth rates. The demand for home test kits is increasing, and many companies are investing in manufacturing large volumes as there is a surge for home test kits in the market. Key Vendors • Abbott • BD • F. Hoffmann-La Roche • Thermo Fisher Scientific • Bio-Rad Laboratories Other Prominent Vendors • AccuBioTech • AIVD Biotech • AMEDA LABORDIAGNOSTIK • ANP Technologies • Angstrom Biotech • ARISTA Biotech • Assure Tech (Hangzhou) • Biolidics • BioMaxima SA • Biopanda Reagents • Biosynex • BIOHIT Healthcare • BioSpeedia • BioMedomics • BioTeke • BTNX • CTK Biotech • CERTEST BIOTEC • Celltrion • Chembio Diagnostics • Ellume • Empowered Diagnostics • FUJIFILM • GUANGZHOU DECHENG BIOTECHNOLOGY • Getein Biotech • GenBody • Hangzhou Alltest Biotech • Hangzhou Clongene Biotech • Healgen Scientific • Wondfo • KH Medical • Lepu Medical Technology • LumiraDx • Mylab Discovery Solutions • Meril Life Sciences • Medicofarma • nal von minden • OraSure Technologies • PerkinElmer • Quidel • Siemens Healthineers • SD Biosensor • Tianjin Era Biology Technology • Xiamen Boson Biotech • Zhejiang Orient Gene Biotech Market Segmentation by Prescription • Professional • At-Home/OTC Market Segmentation by End-User • Hospitals & Clinics • Laboratories • Individuals/Homecare • Others Market Segmentation by Geography • Europe o UK o France o Russia o Italy o Spain o Germany o Netherland o Poland • North America o US o Canada • APAC o India o Australia o South Korea o Malaysia o China o Philippines o Japan • Middle East & Africa o Turkey o Saudi Arabia o South Africa o Iran • Latin America o Brazil o Mexico o Argentina o Peru o Columbia o Chile KEY QUESTIONS ANSWERED: 1. What was the size of the COVID-19 rapid antigen test kits market in 2021? 2. Who are the key players in the COVID-19 rapid antigen test kits market? 3. What are the growth opportunities in the Rapid Covid-19 antigen test kits market? 4. What are the strategies adopted by the players in the COVID-19 rapid antigen test kits market? 5. What are the growth enablers in the COVID-19 rapid antigen test kits market? Read the full report: https://www.reportlinker.com/p06288147/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
Covid vaccines prevented nearly 20 million deaths in the first year after they were introduced, according to the first large modelling study on the topic released Friday.
For an outbreak to be declared a pandemic, health officials must confirm a disease is spreading worldwide.
The disease is spread through close contact and can affect anyone
Photo Illustration by Kelly Caminero/The Daily Beast/Getty/ShutterstockThe monkeypox outbreak that health authorities first noticed in Europe back in May is getting worse. According to the World Health Organization’s latest report, there are over 2,100 confirmed cases, and at least one person has died.Now geneticists finally have enough data to begin getting a handle on how exactly the outbreak started—and where it might be heading.It’s not good news. Monkeypox, a viral disease that causes fever
COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original strain, although some experts suggest they may only offer significant benefits for older and immunocompromised people. Moderna, Pfizer and Novavax have been testing vaccines based on the first BA.1 Omicron variant that became dominant last winter, driving a massive surge in infections. On Wednesday, Moderna said its updated vaccine worked well against more recent Omicron subvariants, and that it was moving forward with plans to ask regulators for approval.
New York City accounts for over 20% of nationwide monkeypox cases, so the city health department is offering Bavarian Nordic's Jynneos vaccine to more people
Is monkeypox a "public health emergency of international concern"? A WHO committee decision could come as early as Friday.
Monkeypox spreads less easily than COVID. Here’s guidance from a local doctor on what to look out for if you want to be cautious about the virus.
Until the arrival of vaccines, polio was one of the most feared diseases, with hundreds of thousands of children paralysed globally every year.
KATERYNA KON/SCIENCE PHOTO LIBRARYAt least six people have died in Florida as the state battles “one of the worst outbreaks of meningococcal disease among gay and bisexual men in U.S. history,” the Centers for Disease Control and Prevention said Wednesday.The outbreak is both sudden and deadly, with the six deaths coming from a total of just 24 cases among gay and bisexual men in Florida this year, the CDC said.The outbreak has left health officials and Florida LGBTQ+ groups scrambling to alert
To reduce the “overall burden of death and disease” from COVID-19, strategies to prevent reinfection are needed, according to researchers.
UK Health Security Agency ‘urgently’ investigating outbreak in northeast London, with officials racing to determine whether community transmission is occurring in the capital
No one's gotten sick yet—but danger lurks
As the World Health Organization convenes its emergency committee Thursday to consider if the spiraling outbreak of monkeypox warrants being declared a global emergency, some experts say WHO’s decision to act only after the disease spilled into the West could entrench the grotesque inequities that arose between rich and poor countries during the coronavirus pandemic. Declaring monkeypox to be a global emergency would mean the U.N. health agency considers the outbreak to be an “extraordinary event” and that the disease is at risk of spreading across even more borders. It would also give monkeypox the same distinction as the COVID-19 pandemic and the ongoing effort to eradicate polio.
The cases are mainly occurring in men who have sex with men, but women are also getting infected, CDC staff member Dr. Agam Rao said at a panel meeting on Thursday. Monkeypox, a viral infection that causes skin lesions, is endemic in certain parts of Africa.
About 1 in 3 COVID-19 cases in the United States now stem from the BA.4 and BA.5 subvariants of the omicron strain, which are on their way to becoming the most dominant coronavirus strains in the country. Data from the Centers for Disease Control and Prevention (CDC) estimates that 11.4 and 23.5 percent of U.S.…
There was such high demand from New Yorkers wanting the shots that the city had to close its vaccination clinic to walk-ins.
“As CEO, my focus is maximizing total shareholder return, driven by improved revenue quality, higher margins, and a balanced capital allocation strategy,” said new CEO Raj Subramaniam on the call.
(Bloomberg) -- Quadria Capital, a health care-focused private equity firm, is exploring a sale of its stake in FV Hospital in Vietnam, according to people familiar with the matter.Most Read from BloombergSupreme Court Overturns Roe, Transforming Abortion-Rights FightJuul’s Vaping Products Are Ordered Off the Market in the USStocks Surge as Bullard, Data Ease Recession Fears: Markets WrapThese Are the World’s Most Liveable Cities in 2022‘Coast to Coast’ Housing Correction Is Coming, Says Moody’s
Coinbase is awaiting approval to operate as an FCM, or futures commission merchant, which would let it offer products directly to clients.